[1] |
LUO Shiping, ZHANG Jie, YU Yushuai, SONG Chuangui.
Advances in targeted therapy for HER2-positive breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 876-886.
|
[2] |
ZHANG Li, LIN Xingyao, SHANG Yun, WANG Qiang.
Progress on the pathological mechanism and treatment of frostbite
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 347-354.
|
[3] |
LI Chenhao, YU Xihua, YAN Wenhao, CHAI Yuxia, LI Yanyan, LI Kun, LI Zeyun.
Research progress on the relationship between pediatric epilepsy and vitamin D
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1299-1306.
|
[4] |
LIU Dan, LIU Ming, JIN Liangyou, PAN Juan, XIN Haoru, LIU Mengyuan, LI Xin, ZHENG Kun, FENG Xiaoling.
Research progress on the antitumor activity of costunolide
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1168-1176.
|
[5] |
LI Miao, YU Qinwei, JIANG Zhenzhou, ZHANG Luyong, .
Regulatory mechanism of LDLR and research progress of its related diseases and drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 946-954.
|
[6] |
CHEN Wenjie, WANG Yabing, CHEN Xiaolin, REN Junling, ZHAO Wanjun, CHEN bin.
Advances in the study of iodine-resistant differentiated thyroid cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 116-120.
|
[7] |
CHEN Ying, YUAN Yonggui.
Research progress in the treatment of depression with monome of Chinese herb, drug pairs, compound prescriptions and Chinese patent drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 586-593.
|
[8] |
PEI Qinghua, SUN Jianli.
Research progress of Osimertinib acquired resistance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(1): 105-112.
|
[9] |
LIU Qingwu, CHEN Jia, MENG Yujiao, FENG Fang, GUO Xiwei, GUO Jianning, ZHANG Jinchao, LIN Yan, HE Xiujuan, LI Ping.
Research progresses of wound repair by exosomes derived from mesenchymal stem cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(7): 826-832.
|
[10] |
SUN Shanshan, QU Lianyue, DU Rongrong, LIN Jianyang.
Research progress on drug therapy of hyperuricemia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(5): 589-594.
|
[11] |
CHEN Guangliang, ZHOU Yuanfeng, ZHANG Ying.
Research progress in medicine for treating gout and hyperuricemia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(1): 104-109.
|
[12] |
WANG Hai-nan.
Progresses in studies on pharmacologic effects of ginsenosides
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(11): 1201-1206.
|